An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells

被引:37
作者
Aaronson, David S.
Muller, Melissa
Neves, Susana R.
Chung, Wen-Chen
Jayaram, Gomathi
Iyengar, Ravi
Ram, Prahlad T.
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77054 USA
[2] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY USA
关键词
EGF; Stat3; prostate cancer; IL-6; signaling network;
D O I
10.1016/j.mce.2007.02.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Dynamic modulation of information flow within signaling networks allows the cell to respond to micro-environmental changes. This property of the cell, while being essential to survival and eliciting appropriate responses, can also be detrimental to the organism by allowing cancerous cells to evade regulation and proliferate. We determined if changes in expression levels of transcriptional regulators and their interactions could alter routing within signaling networks in prostate cancer cells. Increasing the protein levels of the signal transducer and activator of transcription 3 (Stat3) led to Stat3-androgen receptor (AR) complex formation in response to epidermal growth factor (EGF) and interleukin-6 (IL-6) stimulation. Increasing the protein levels of Stat3 increased the EGF induced transcriptional activation of the androgen receptor. Androgen pre-treatment increased Stat3 protein levels in an IL-6 autocrine/paracrine dependent manner in the cells suggesting a feedback loop within cells. Increased Stat3-AR complex leads to a change in the routing of the epidermal growth factor signal allowing the androgen receptor to become activated in a Stat3 dependent manner. Understanding interactions and changes in signal flow within the cell is important to our understanding of signaling networks as well as our ability to identify cellular targets for novel therapies to inhibit cancer progression. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 28 条
  • [1] A road map for those who don't know JAK-STAT
    Aaronson, DS
    Horvath, CM
    [J]. SCIENCE, 2002, 296 (5573) : 1653 - 1655
  • [2] Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault
    Arnold, JT
    Isaacs, JT
    [J]. ENDOCRINE-RELATED CANCER, 2002, 9 (01) : 61 - 73
  • [3] STATs in oncogenesis
    Bowman, T
    Garcia, R
    Turkson, J
    Jove, R
    [J]. ONCOGENE, 2000, 19 (21) : 2474 - 2488
  • [4] Stat3 activation is required for cellular transformation by v-src
    Bromberg, JF
    Horvath, CM
    Besser, D
    Lathem, WW
    Darnell, JE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (05) : 2553 - 2558
  • [5] CHEN T, 2000, P 10 INT OFFSH POL E, V3, P60
  • [6] CULIG Z, 1994, CANCER RES, V54, P5474
  • [7] Stat3 activation in prostatic carcinomas
    Dhir, R
    Ni, ZY
    Lou, W
    DeMiguel, F
    Grandis, JR
    Gao, AC
    [J]. PROSTATE, 2002, 51 (04) : 241 - 246
  • [8] Drachenberg DE, 1999, PROSTATE, V41, P127, DOI 10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO
  • [9] 2-H
  • [10] The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: modifications to the androgen receptor
    Edwards, J
    Bartlett, JMS
    [J]. BJU INTERNATIONAL, 2005, 95 (09) : 1320 - 1326